MedTec
ActiveSummary
MedTec has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €6k and a net result of €7k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 95% of 918 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.5% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100▲+100
Solvency100▲+81
Growth58=
Track record100
Bankruptcy probability, 12 months
1.5%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €500 at 30 days acceptable
cash: 85% of total assets, and 0% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 77
Relative position
BE, all sectors
reference
Rental and leasing activities (NACE 77)
about 44% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
100%
Return on assets
108.6%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-03-2026, 144 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
144 d early
2024
119 d early
2023
127 d early
2022
111 d early
2021
23 d early
2020
14 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€6k
2024 · €-548
2020: €14khighest in 6 years
2021: €8k▼ -42.8% vs 2020
2022: €2k▼ -79.5% vs 2021
2023: €-5k▼ -384% vs 2022lowest in 6 years
2024: €-548▲ +88.4% vs 2023
2025: €6k▲ +1269% vs 2024
2020 → 2025
Total assets
€6k▼ 33.8%
2024 · €10k
2020: €27khighest in 6 years
2021: €19k▼ -30.4% vs 2020
2022: €12k▼ -35.2% vs 2021
2023: €6k▼ -54.5% vs 2022lowest in 6 years
2024: €10k▲ +76.0% vs 2023
2025: €6k▼ -33.8% vs 2024
2020 → 2025
Net result
€7k
2024 · €-6k
2020: €-6k
2021: €-6k▼ -3.9% vs 2020
2022: €-6k▼ -6.3% vs 2021lowest in 6 years
2023: €-6k▲ +0.8% vs 2022
2024: €-6k▲ +8.9% vs 2023
2025: €7k▲ +219% vs 2024highest in 6 years
2020 → 2025
Working capital
€-2k▲ 77.3%
2023 · €-9k
2020: €222highest in 5 years
2021: €-4k▼ -1751% vs 2020
2022: €-6k▼ -73.9% vs 2021
2023: €-9k▼ -48.5% vs 2022lowest in 5 years
2024: €-2k▲ +77.3% vs 2023
2020 → 2024
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€8k-€2k▼ 79.5%€-5k€-548▲ 88.4%€6k
2021: €8khighest in 5 years
2022: €2k▼ -79.5% vs 2021
2023: €-5k▼ -384% vs 2022lowest in 5 years
2024: €-548▲ +88.4% vs 2023
2025: €6k▲ +1269% vs 2024
Operating result€-6k-€-6k▼ 6.1%€-6k▲ 0.7%€-6k▲ 9.2%€7k
2021: €-6k
2022: €-6k▼ -6.1% vs 2021lowest in 5 years
2023: €-6k▲ +0.7% vs 2022
2024: €-6k▲ +9.2% vs 2023
2025: €7k▲ +222% vs 2024highest in 5 years
Net result€-6k-€-6k▼ 6.3%€-6k▲ 0.8%€-6k▲ 8.9%€7k
2021: €-6k
2022: €-6k▼ -6.3% vs 2021lowest in 5 years
2023: €-6k▲ +0.8% vs 2022
2024: €-6k▲ +8.9% vs 2023
2025: €7k▲ +219% vs 2024highest in 5 years
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2025: €7k after a loss of €6k in 2024, the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €6k
Fixed assets
€882 ▼ 44.7%
Current assets
€6k ▼ 31.7%
Key figures and ratios
EBITDA
€8k▲
2024 · €-2k
Cash flow
€8k▲
2024 · €-2k
Solvency
100.0%▲
2024 · -5.7%
ROE
108.6%
ROA
108.6%▲
2024 · -60.1%
Interest coverage
161.31▲
2024 · -34.41
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 25 lines
Balance sheet
Code20242025
Assets
Total assets20/58€10k€6k▼
Fixed assets21/28€2k€882▼
Intangible fixed assets21€2k€882▼
Current assets29/58€8k€6k▼
Cash at bank and in hand54/58€8k€5k▼
Deferred charges and accrued income490/1-€77
Equity and liabilities
Total equity and liabilities10/49€10k€6k▼
Equity10/15€-548€6k▲
Contributions10/11€30k€30k=
Profit (loss) carried forward14€-31k€-24k▲
Amounts payable17/49€10k-
Amounts payable within one year42/48€10k-
Other amounts payable47/48€10k-
Income statement
Code20242025
Non-recurring operating income76A-€10k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3k€1k▼
Other operating charges640/8€878€823▼
Gross operating margin9900€-1k€9k▲
Operating profit (loss)9901€-6k€7k▲
Financial charges65/66B€69€50▼
Recurring financial charges65€69€50▼
Profit (loss) for the period before taxes9903€-6k€7k▲
Profit (loss) for the period9904€-6k€7k▲
Profit (loss) for the period to be appropriated9905€-6k€7k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-31k€-24k▲
Profit (loss) brought forward from the previous period14P€-25k€-31k▼
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | - | €10k | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €4k | €4k | €4k | €3k | €1k | ▼ 68.8% |
| Other operating charges640/8 | €468 | €469 | €937 | €878 | €823 | ▼ 6.2% |
| Gross operating margin9900 | €-2k | €-2k | €-2k | €-1k | €9k | ▲ 701% |
| Operating profit (loss)9901 | €-6k | €-6k | €-6k | €-6k | €7k | ▲ 222% |
| Financial charges65/66B | €53 | €67 | €59 | €69 | €50 | ▼ 27.0% |
| Recurring financial charges65 | €53 | €67 | €59 | €69 | €50 | ▼ 27.0% |
| Profit (loss) for the period before taxes9903 | €-6k | €-6k | €-6k | €-6k | €7k | ▲ 219% |
| Profit (loss) for the period9904 | €-6k | €-6k | €-6k | €-6k | €7k | ▲ 219% |
| Profit (loss) for the period to be appropriated9905 | €-6k | €-6k | €-6k | €-6k | €7k | ▲ 219% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €19k | €12k | €6k | €10k | €6k | ▼ 33.8% |
| Fixed assets21/28 | €12k | €8k | €5k | €2k | €882 | ▼ 44.7% |
| Intangible fixed assets21 | €12k | €8k | €5k | €2k | €882 | ▼ 44.7% |
| Current assets29/58 | €7k | €4k | €780 | €8k | €6k | ▼ 31.7% |
| Cash at bank and in hand54/58 | €7k | €4k | €780 | €8k | €5k | ▼ 32.6% |
| Deferred charges and accrued income490/1 | - | - | - | - | €77 | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €19k | €12k | €6k | €10k | €6k | ▼ 33.8% |
| Equity10/15 | €8k | €2k | €-5k | €-548 | €6k | ▲ 1,269% |
| Contributions10/11 | €20k | €20k | €20k | €30k | €30k | = |
| Profit (loss) carried forward14 | €-12k | €-18k | €-25k | €-31k | €-24k | ▲ 22.8% |
| Amounts payable17/49 | €11k | €10k | €10k | €10k | - | - |
| Amounts payable within one year42/48 | €11k | €10k | €10k | €10k | - | - |
| Trade debts44 | €254 | €198 | - | - | - | - |
| Suppliers440/4 | €254 | €198 | - | - | - | - |
| Other amounts payable47/48 | €10k | €10k | €10k | €10k | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €-6k | €-6k | €-6k | €-6k | €7k | ▲ 219% |
| + Depreciation and write-downs630 | €4k | €4k | €4k | €3k | €1k | ▼ 68.8% |
| Operating cash flow (approximation) | €-2k | €-3k | €-3k | €-2k | €8k | ▲ 430% |
| Investment in fixed assets (approximation) | - | €0 | €-482 | €-271 | €-346 | ▼ 27.7% |
| Change in cash | - | €-3k | €-3k | €7k | €-3k | ▼ 136% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
09-03
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Back to profitnet €7k
Net result €7k after 5 loss-making years.
03-04
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
26-03
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
11-04
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Weakest financial yearnet €-6k
Net result drops to €-6k, the lowest in the series; recovery starts the following year.
08-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
17-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2019
Ground area
5,961 m²
Building footprint
419 m²
Volume, LiDAR
1,739 m³
Parcel 44017A0086/00G000, Flanders · tallest building 9.3 m, ±1 floor. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
MedTec
since 20192.293.177.691
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44017A0086/00G000 | Flanders | 5,961 m² | 1 · 418 m² | 9.3 m · 1 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
LeBonBail
BE 0597.636.497
Beauvechain · Eq €6,496
Beisol Pharma Poederlee
BE 0544.651.040
Lubbeek · Eq €6,086
Beisol Pharma Tienen
BE 0544.648.961
Lubbeek · Eq €6,758
Quinconce 10
BE 1001.926.559
La Louvière · Eq €5,858
POLYCLICK
BE 0777.535.172
De Panne · Eq €7,771
Of 421 companies in sector 77400 we hold annual accounts for 152. 60 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded12-08-2019
Fiscal year end31-12
Activities, NACEBEL 2025
77400Rental and leasing activities
72109Other research and development on natural sciences
82990Other business support services
Contact
Website
www.medtec.be
E-mail
info@medtec.be
Scores and ratios are computed by Checked and are not a credit decision.